VivoSim Labs (VIVS) Invested Capital (2011 - 2024)

VivoSim Labs (VIVS) posted Invested Capital of $717000.0 for Q4 2024, down 98.85% on a QoQ basis from $62.4 million in Q1 2017.

Analysis

VivoSim Labs (VIVS) Invested Capital (2011 - 2024) Analysis & Trends

VivoSim Labs has reported Invested Capital for 8 years, with the latest figure at $717000.0 in Q4 2024.

On a quarterly basis, Invested Capital changed N/A year-over-year to $717000.0 in Q4 2024; TTM through Dec 2024 was $717000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $62.4 million, changed 0.28% from the prior year.
Invested Capital was $717000.0 for Q4 2024 at VivoSim Labs, down from $62.4 million in the prior quarter.
The five-year high for Invested Capital was $717000.0 in Q4 2024, with the low at $717000.0 in Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Iqvia Holdings	44.72 Bn	42.64 Bn	1.44 Bn	22.30 Bn
2	Medpace Holdings	17.37 Bn	16.87 Bn	201.64 Mn	-
3	Icon	13.65 Bn	12.72 Bn	479.29 Mn	12.77 Bn
4	Charles River Laboratories International	13.13 Bn	12.94 Bn	452.07 Mn	5.47 Bn
5	Fortrea Holdings	1.89 Bn	1.72 Bn	139.20 Mn	1.58 Bn
6	Evotec SE	574.75 Mn	148.87 Mn	-	1.33 Bn
7	Ginkgo Bioworks Holdings	439.63 Mn	355.09 Mn	18.44 Mn	-
8	Champions Oncology	69.43 Mn	65.03 Mn	7.70 Mn	-
9	MindWalk Holdings	51.76 Mn	46.29 Mn	1.61 Mn	-
10	VivoSim Labs	1.37 Mn	1.37 Mn	-	-

Historic Data

Download Data